cdn mobile
TARGET: 2ND HALF OF 2021

Mandaue firms eye vaccine shots for 50K workers

By: Mary Rose Sagarino - Multimedia Correspondent - CDN Digital | March 25,2021 - 06:17 PM

Steven Yu, Mandaue Chamber of Commerce and Industry president, says the group has been helping facilitate the procurement of vaccines for the private sector in Mandaue City. | Mary Rose Sagarino screen grab of Zoom Meeting with Yu

Steven Yu, Mandaue Chamber of Commerce and Industry president, says the group has been helping facilitate the procurement of vaccines for the private sector in Mandaue City. | Mary Rose Sagarino screen grab of Zoom Meeting with Yu

MANDAUE CITY, Philippines — About 50,000 employees in Mandaue City will soon be vaccinated against the coronavirus disease 2019 (COVID-19).

Steven Yu, Mandaue Chamber of Commerce and Industry (MCCI) president, said they were expecting at least 100,000 doses of Moderna COVID-19 vaccine to arrive in the city in the third or fourth quarter of the year or on the second half of the year.

Yu said since private companies were not allowed to procure COVID-19 vaccines before, they have tied up with the International Container Terminal Services, Inc. (ICTSI) foundation.

FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” are seen in front of a displayed Moderna logo in this illustration taken in 2020. REUTERS

The MCCI has been facilitating Moderna vaccine from the foundation to various businessmen and members of MCCI who wanted to help and provide vaccines for their employees.

He said the ICTSI foundation is procuring 20 million doses of Moderna vaccines, 13 million of which will be donated to the national government while the 7 million for the private sectors with the MCCI being allocated with at least 100,000 as a facilitator.

He said this would help and supplement the vaccines of the government.

Read: More frontliners in City vaccinated

It will be given for free and employees will not be required to be vaccinated only those who are willing to receive the vaccine.

Yu said anybody, who would attempt to sell the vaccine, would be blacklisted from the ICTSI foundation.

He said that once the vaccine would arrive in the city they would coordinate with the government, although most of the businesses would be willing to shoulder the expenses for their vaccination. Businesses plan to tap private sector for the inocluation of their employees as the government also has its vaccination program.

Read: Firms can now buy own vaccines – Palace

Meanwhile, Yu said they were still studying the Implementing Rules and Regulations (IRR).

Earlier, the IRR of Republic Act 11525 or the Covid-19 Vaccination Law had been amended to allow private companies to purchase COVID-19 vaccines for their employees.

He said they were still evaluating it because they wanted a clear direction from the government and the role of the private sectors on the tripartite agreement. 

/dbs

Related Stories

AstraZeneca rollout in CV extended to Mar. 31

Palace to mayors: Don’t skip vaccine line or we lose 44M doses of COVID-19 jabs

DILG to issue show cause order vs Mingla mayor for taking vaccine; LGU says no HCWs displaced

 

50K more HCWs in CV to be vaccinated

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Mandaue Chamber of Commerce and Industry, MCCI, Moderna, Steven Yu
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.